Quant Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.88 %Nav, as on 11-06-2025

  • Previous Nav

  • Net Change on 11-06-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty India Consumption - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 13.75 24.63 21.57 1.80 8,352.16
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 23.36 28.91 24.81 1.90 5,507.52
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 14.10 24.03 21.02 2.12 1,231.67
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 20.96 25.58 21.49 2.27 1,062.19

Fund Holdings as on 31-May-2025

  • TREPS 02-Jun-2025 DEPO 10

  • Divi's Laboratories Limited

  • Aster DM Healthcare Limited

  • RPG Life Sciences Limited

  • Sequent Scientific Limited

  • Pfizer Ltd

  • Lupin Limited 26/06/2025

  • Alivus Life Sciences

  • Zydus Wellness Ltd

  • Aurobindo Pharma Limited

  • HDFC Life Insurance Co Ltd

  • SMS Pharmaceuticals Limited

  • HFCL Limited

  • Dr. Reddy's Laboratories Limited 26/06/2025

  • Sun Pharmaceutical Industries Limited

  • Sun Pharmaceutical Industries Limited 26/06/2025

  • Lupin Limited

  • Suraksha Diagnostic Limited

  • Aurobindo Pharma Limited 26/06/2025

  • 91 Days Treasury Bill 17-Jul-2025

  • 91 Days Treasury Bill 21-Aug-2025

  • 91 Days Treasury Bill 28-Aug-2025

  • Laxmi Dental Limited

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Consumer Food

  • Insurance

  • Telecom-Infrastructure

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • Sovereign

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹417.03 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty India Consumption - TRI as secondary index.

The NAV of Quant Healthcare Fund ended up ₹0.14(0.88%)yesterday to ₹15.6868.

Among its top 3 holdings the fund has exposure to TREPS 02-Jun-2025 DEPO 10, and

The Quant Healthcare Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000